126 related articles for article (PubMed ID: 19468658)
1. Severe adverse drug reaction to gadobenate dimeglumine.
Singer BD; Woodrick RS; Pedicano JB
ScientificWorldJournal; 2009 May; 9():363-5. PubMed ID: 19468658
[TBL] [Abstract][Full Text] [Related]
2. Anaphylactic reaction and cardiac arrest due to gadobenate dimeglumine.
Virtos M; Ruiz S; Mokrane FZ; Rousseau H; Georges B; Fourcade O; Conil JM
Anaesth Crit Care Pain Med; 2015 Aug; 34(4):247-8. PubMed ID: 26004876
[No Abstract] [Full Text] [Related]
3. A case of gadobenate dimeglumine-induced anaphylactic shock: a case report.
Huang J; Liu Z; Jiang C; Xu L; Zheng W
Ann Palliat Med; 2021 Jun; 10(6):7126-7131. PubMed ID: 34154335
[TBL] [Abstract][Full Text] [Related]
4. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
5. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
Tishler S; Hoffman JC
AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
[No Abstract] [Full Text] [Related]
6. Small bowel angioedema due to intravenous administration of gadobenate dimeglumine.
Maarek R; Sellier N; Seror O; Sutter O
Diagn Interv Imaging; 2019; 100(7-8):459-460. PubMed ID: 30935862
[No Abstract] [Full Text] [Related]
7. A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology.
Runge VM; Armstrong MR; Barr RG; Berger BL; Czervionke LF; Gonzalez CF; Halford HH; Kanal E; Kuhn MJ; Levin JM; Low RN; Tanenbaum LN; Wang AM; Wong W; Yuh WT; Zoarski GH
Invest Radiol; 2001 Feb; 36(2):65-71. PubMed ID: 11224753
[TBL] [Abstract][Full Text] [Related]
8. Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage.
Colosimo C; Ruscalleda J; Korves M; La Ferla R; Wool C; Pianezzola P; Kirchin MA
Invest Radiol; 2001 Feb; 36(2):72-81. PubMed ID: 11224754
[TBL] [Abstract][Full Text] [Related]
9. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the incidence of nephrogenic systemic fibrosis in patients with moderate renal insufficiency administered gadobenate dimeglumine for MRI.
Bryant BJ; Im K; Broome DR
Clin Radiol; 2009 Jul; 64(7):706-13. PubMed ID: 19520215
[TBL] [Abstract][Full Text] [Related]
11. Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections.
Abujudeh HH; Kosaraju VK; Kaewlai R
AJR Am J Roentgenol; 2010 Feb; 194(2):430-4. PubMed ID: 20093606
[TBL] [Abstract][Full Text] [Related]
12. Safety and Diagnostic Efficacy of Gadobenate Dimeglumine in MRI of the Brain and Spine of Neonates and Infants.
Enterline DS; Martin KW; Parmar HA; Triulzi FM; Colosimo C
AJNR Am J Neuroradiol; 2019 Dec; 40(12):2001-2009. PubMed ID: 31727753
[TBL] [Abstract][Full Text] [Related]
13. Incidence of immediate gadolinium contrast media reactions.
Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
Cheong BY; Duran C; Preventza OA; Muthupillai R
AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
Witte RJ; Anzai LL
AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
[TBL] [Abstract][Full Text] [Related]
16. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
[TBL] [Abstract][Full Text] [Related]
17. Cardiac electrophysiologic monitoring after injection of gadobenate dimeglumine versus placebo in healthy volunteers and patients with cardiovascular disease.
Pirovano G; Goodman DB; Halemane U; Venetianer C; Kirchin MA; Spinazzi A
Radiology; 2004 Nov; 233(2):555-65. PubMed ID: 15375224
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
Altun E; Martin DR; Wertman R; Lugo-Somolinos A; Fuller ER; Semelka RC
Radiology; 2009 Dec; 253(3):689-96. PubMed ID: 19789233
[TBL] [Abstract][Full Text] [Related]
19. Adverse allergic reactions to linear ionic gadolinium-based contrast agents: experience with 194, 400 injections.
Aran S; Shaqdan KW; Abujudeh HH
Clin Radiol; 2015 May; 70(5):466-75. PubMed ID: 25626627
[TBL] [Abstract][Full Text] [Related]
20. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
